Additional data from the STORM study demonstrate vision quality to be a major driver of the patient decision to undergo surgerySAN DIEGO--(BUSINESS WIRE)--Trefoil Therapeutics, a clinical-stage biotechnology company focused on developing novel new therapeutic agents to treat corneal diseases, today announced that TT...